APRILE, LARA
 Distribuzione geografica
Continente #
NA - Nord America 1.759
EU - Europa 1.453
AS - Asia 788
SA - Sud America 90
AF - Africa 41
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.135
Nazione #
US - Stati Uniti d'America 1.736
GB - Regno Unito 375
RU - Federazione Russa 356
CN - Cina 253
SG - Singapore 251
IE - Irlanda 198
VN - Vietnam 131
SE - Svezia 101
UA - Ucraina 99
DE - Germania 92
IT - Italia 80
BR - Brasile 69
FR - Francia 68
HK - Hong Kong 45
FI - Finlandia 30
ZA - Sudafrica 26
KR - Corea 23
IN - India 21
CA - Canada 14
PL - Polonia 13
BD - Bangladesh 11
JP - Giappone 9
ES - Italia 7
IQ - Iraq 7
MX - Messico 7
AR - Argentina 5
BE - Belgio 5
TR - Turchia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
LT - Lituania 4
MY - Malesia 4
NG - Nigeria 4
NL - Olanda 4
PT - Portogallo 4
TN - Tunisia 4
UZ - Uzbekistan 4
AL - Albania 3
AU - Australia 3
BG - Bulgaria 3
CL - Cile 3
CO - Colombia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EC - Ecuador 3
ID - Indonesia 3
IR - Iran 3
PK - Pakistan 3
DK - Danimarca 2
KE - Kenya 2
KZ - Kazakistan 2
SA - Arabia Saudita 2
SM - San Marino 2
AT - Austria 1
AZ - Azerbaigian 1
BH - Bahrain 1
EG - Egitto 1
EU - Europa 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
SV - El Salvador 1
UY - Uruguay 1
Totale 4.135
Città #
Southend 335
Dallas 238
Dublin 197
Fairfield 160
Singapore 139
Chandler 111
Ashburn 109
Woodbridge 102
Moscow 91
Jacksonville 80
Santa Clara 80
Wilmington 69
Beijing 66
Ann Arbor 61
Houston 59
San Jose 58
Seattle 54
Cambridge 45
Ho Chi Minh City 45
Hong Kong 42
The Dalles 42
Hanoi 39
Nanjing 32
New York 32
Princeton 32
Los Angeles 27
Hefei 24
Johannesburg 24
Seoul 23
Council Bluffs 21
Siena 20
Lauterbourg 18
Munich 14
Boardman 13
Helsinki 13
Orem 13
São Paulo 12
Shanghai 11
Nanchang 10
Poplar 10
Warsaw 10
Nuremberg 9
Tokyo 9
Atlanta 8
Chennai 8
Columbus 8
Da Nang 8
Dong Ket 8
London 8
Buffalo 7
San Mateo 7
Zhengzhou 7
Denver 6
Hebei 6
San Diego 6
San Francisco 6
Tianjin 6
Brooklyn 5
Brussels 5
Florence 5
Milan 5
Montreal 5
Shenyang 5
Stockholm 5
Abuja 4
Boston 4
Cagliari 4
Chicago 4
Frankfurt am Main 4
Guangzhou 4
Haiphong 4
Mexico City 4
Norwalk 4
Phoenix 4
Poggibonsi 4
Taizhou 4
Tashkent 4
Ankara 3
Baghdad 3
Brno 3
Caracas 3
Cascavel 3
Changsha 3
Curitiba 3
Düsseldorf 3
Hangzhou 3
Hyderabad 3
Lisbon 3
New Delhi 3
Redondo Beach 3
Tunis 3
Vienna 3
Arezzo 2
Arienzo 2
Augusta 2
Bengaluru 2
Bethesda 2
Brescia 2
Campi Bisenzio 2
Castiglion Fiorentino 2
Totale 2.846
Nome #
Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status? 285
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients 276
Atherothrombotic risk assessment during tyrosine kinase inhibitors treatment in chronic myeloid leukemia patients: new insight? 267
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 250
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may explain increased atherothrombotic risk during TKI treatment in chronic myeloid leukemia patients 244
BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial 238
Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccination 230
Identification of a Novel P190-Derived Breakpoint Peptide Suitable for Peptide Vaccine Therapeutic Approach in Ph+ Acute Lymphoblastic Leukemia Patients. 229
Peptide vaccines for hematological malignancies: a missed promise? 227
A solitary uterine relapse in T-cell Acute Lymphoblastic Leukaemia: CT features and pathologic correlation 217
Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib 215
Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy. 213
Flow-cytometry evaluation of residual Leukemia Stem Cells in Chronic Myeloid Leukemia patients: feasibility and clinical application. 209
FLT3 inhibitors in the management of acute myeloid leukemia 207
Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion 182
Evaluation of Residual CD34+/Ph+ Stem Cells In Chronic Myeloid Leukemia Patients In Complete Cytogenetic Response during First Line Nilotinib Therapy 170
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study 169
null 130
Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy 125
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T‐cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study 84
Totale 4.167
Categoria #
all - tutte 11.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202184 0 0 0 0 0 0 0 0 0 22 23 39
2021/2022229 24 16 12 27 14 11 11 7 10 27 23 47
2022/2023359 19 30 48 52 31 79 1 33 35 5 17 9
2023/2024275 12 7 27 4 5 75 109 11 0 5 2 18
2024/2025485 6 19 62 19 72 21 5 23 70 14 64 110
2025/20261.464 97 195 158 212 367 64 209 33 43 86 0 0
Totale 4.167